RenovoRx, Inc. (RNXT): Nasdaq/NYSE listing notice — RenovoRx receives Nasdaq delisting notice for equity below $2.5M minimum

RenovoRx, Inc.

Stockholders' equity of $1,188,000 as of June 30, 2023, below Nasdaq's $2.5M minimum requirement.
Company also fails alternative standards of $35M market value or $500K net income from continuing operations.
Has 45 days (by Oct 5, 2023) to submit plan to regain compliance; Nasdaq may grant up to 180-day extension.
Management intends to submit compliance plan but cannot assure acceptance or ability to regain compliance.

item 3.01

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.99

RenovoRx, Inc. received a nasdaq deficiency notice notice regarding stockholders equity (rules 5550(b)(1)).

Exchange: nasdaq
Notice: deficiency notice
Deficiency: stockholders equity
Rules: 5550(b)(1)

Exact text from the filing

August 21, 2023, RenovoRx, Inc. (the “Company”) received a letter (the “Letter”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) indicating that, as of August 18, 2023, the Company was not in compliance with the minimum stockholders’ equity requirement for continued listing on The Nasdaq Capital Market, under Listing Rule 5550(b)(1), because the Company’s stockholders’ equity of $1,188,000 as reported in the Company’s Quarterly Report on Form 10-Q for the period ended June 30, 2023 was below the required minimum of $2.5 million, and because, as of June 30

View on SEC.gov

Browse all listing & compliance notices →

RenovoRx, Inc. filing history →

Source: SEC EDGAR

accession 0001493152-23-030228

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.